Adeona Nabs Another $400k In Grant Money

Adeona Pharmaceuticals (AMEX:AEN) said Monday that it received another $409,426 in grant money from the National Multiple Sclerosis Society. The Ann Arbor, MI-based company is currently conducting a clinical trial of its Trimesta drug to treat female MS.

Trending on Xconomy